Viking Therapeutics (VKTX) Shares Issued (2015 - 2026)

Viking Therapeutics has disclosed Shares Issued across 12 years of filings, most recently posting $450000.0 for Q1 2026.

• Shares Issued for Q1 2026 came in at $450000.0, up 28.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (down 67.11% YoY), and the FY2025 annual result was $2.0 million, down 80.77% from the prior year.
• Shares Issued came in at $450000.0 for Q1 2026 at Viking Therapeutics, down from $664000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $4.4 million in Q1 2024 to a low of -$200000.0 in Q4 2023.
• The 5-year median for Shares Issued is $587000.0 (2024), against an average of $1.3 million.
• Peak annual rise in Shares Issued reached 2995.24% in 2023, while the deepest fall reached 233.33% in 2023.
• Viking Therapeutics' Shares Issued stood at $150000.0 in 2022, then slumped by 233.33% to -$200000.0 in 2023, then jumped by 393.5% to $587000.0 in 2024, then climbed by 13.12% to $664000.0 in 2025, then tumbled by 32.23% to $450000.0 in 2026.
• The last three Shares Issued figures came in at $450000.0 (Q1 2026), $664000.0 (Q4 2025), and $480000.0 (Q3 2025), per Business Quant data.